Stock Events

Stock Events

Can-Fite Biopharma (CANF) Q1 2026 Earnings

26MarConfirmed

Q4 2024

Q2 2025

Q3 2025

Q1 2026

-2.99

-1.99

-0.99

0

Details

Expected EPS

0

Actual EPS

-2.985

Surprise EPS

-2.99

Surprise Percent

+∞%

Description

Can-Fite Biopharma (CANF) has reported earnings of -2.985 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.